SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-010993
Filing Date
2022-09-08
Accepted
2022-09-08 16:30:27
Documents
2
Period of Report
2022-09-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-57083.html 4  
1 PRIMARY DOCUMENT marketforms-57083.xml 4 4256
2 POA DOCUMENT poa.htm EX-24 2965
  Complete submission text file 0001214659-22-010993.txt   8671
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Truitt Kenneth (Reporting) CIK: 0001946056 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 221234162